Posted by jealibeanz on February 1, 2007, at 4:15:01
In reply to Re: Updates on pipeline drugs? » jealibeanz, posted by XanyADDam on February 1, 2007, at 2:51:14
"Yeah...I checked out http://www.neurotransmitter.net/newdrugs.html. The drugs you were referring to, SR 58611 and Saredutant (SR 48968)...SR 58611 is a selective beta-3-adrenoceptor agonist, used to treat depression and anxiety. As far as its development phase: A supplemental NDA is possible in 2007. Saredutant, an NK2 antagonist, has been indicated in the treatment of depression and anxiety as well. It is, as you stated, currently in Phase III."
That is where I get my info from. I wondering where they get theirs from and wanted to know if anyone knew of anyupdates.The pharmaceutical websites a verrry behind, some almost a year. If contacted, they don't give out much information.
The FDA website has nothing to offer unless an NDA has been submitted.
poster:jealibeanz
thread:728407
URL: http://www.dr-bob.org/babble/20070201/msgs/728676.html